A detailed history of Jones Financial Companies Lllp transactions in Abb Vie Inc. stock. As of the latest transaction made, Jones Financial Companies Lllp holds 104,932 shares of ABBV stock, worth $17.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
104,932
Previous 63,027 66.49%
Holding current value
$17.8 Million
Previous $10.8 Million 91.68%
% of portfolio
0.02%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $6.87 Million - $8.35 Million
41,905 Added 66.49%
104,932 $20.7 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $4.13 Million - $4.82 Million
26,690 Added 73.45%
63,027 $10.8 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $725,263 - $826,369
4,538 Added 14.27%
36,337 $6.62 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $326,524 - $367,743
2,373 Added 8.06%
31,799 $4.93 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $1.2 Million - $1.39 Million
-8,975 Reduced 23.37%
29,426 $4.39 Million
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $3.6 Million - $4.48 Million
27,159 Added 241.59%
38,401 $5.17 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $52,927 - $60,953
-366 Reduced 3.15%
11,242 $1.79 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $146,055 - $175,158
1,056 Added 10.01%
11,608 $1.88 Million
Q3 2022

Nov 03, 2022

SELL
$134.21 - $153.93 $130,854 - $150,081
-975 Reduced 8.46%
10,552 $1.42 Million
Q2 2022

Aug 08, 2022

BUY
$137.62 - $174.96 $2,614 - $3,324
19 Added 0.17%
11,527 $1.77 Million
Q1 2022

May 02, 2022

SELL
$131.98 - $163.75 $20,720 - $25,708
-157 Reduced 1.35%
11,508 $1.87 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $37,600 - $47,575
-350 Reduced 2.91%
11,665 $1.58 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $24,897 - $28,262
-234 Reduced 1.91%
12,015 $1.3 Million
Q2 2021

Aug 12, 2021

SELL
$105.21 - $117.21 $280,279 - $312,247
-2,664 Reduced 17.86%
12,249 $1.38 Million
Q1 2021

Apr 30, 2021

BUY
$102.3 - $112.62 $91,865 - $101,132
898 Added 6.41%
14,913 $1.61 Million
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $24,871 - $33,579
309 Added 2.25%
14,015 $1.5 Million
Q3 2020

Oct 29, 2020

SELL
$85.91 - $100.83 $443,553 - $520,585
-5,163 Reduced 27.36%
13,706 $1.2 Million
Q2 2020

Jul 31, 2020

SELL
$73.37 - $98.18 $154,150 - $206,276
-2,101 Reduced 10.02%
18,869 $1.85 Million
Q1 2020

May 01, 2020

BUY
$64.5 - $97.79 $262,515 - $398,005
4,070 Added 24.08%
20,970 $1.6 Million
Q4 2019

Jan 21, 2020

BUY
$72.13 - $90.25 $61,238 - $76,622
849 Added 5.29%
16,900 $1.5 Million
Q3 2019

Oct 31, 2019

SELL
$62.98 - $75.72 $9,887 - $11,888
-157 Reduced 0.97%
16,051 $1.22 Million
Q2 2019

Aug 02, 2019

SELL
$65.7 - $83.98 $16,490 - $21,078
-251 Reduced 1.53%
16,208 $1.18 Million
Q1 2019

May 03, 2019

SELL
$77.14 - $90.79 $209,203 - $246,222
-2,712 Reduced 14.15%
16,459 $1.33 Million
Q4 2018

Feb 11, 2019

SELL
$77.85 - $96.01 $136,393 - $168,209
-1,752 Reduced 8.37%
19,171 $1.77 Million
Q3 2018

Nov 08, 2018

SELL
$88.91 - $98.84 $193,290 - $214,878
-2,174 Reduced 9.41%
20,923 $1.98 Million
Q2 2018

Aug 08, 2018

SELL
$89.78 - $106.23 $1,436 - $1,699
-16 Reduced 0.07%
23,097 $2.14 Million
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $712,525 - $954,138
-7,744 Reduced 25.1%
23,113 $2.19 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $203,211 - $222,838
-2,269 Reduced 6.85%
30,857 $2.98 Million
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $616,635 - $787,634
-8,828 Reduced 21.04%
33,126 $2.94 Million
Q2 2017

Aug 14, 2017

BUY
N/A
41,954
41,954 $3.04 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.